Kalaris Therapeutics (KLRS)

NASDAQ:KLRS

US Market

KLRS

Kalaris Therapeutics

RESEARCH TOOLSreports

Want to see KLRS full AI Analyst Report?

Kalaris Therapeutics (KLRS) Ownership - Who Owns Kalaris Therapeutics?

383 Followers

Kalaris Therapeutics (KLRS) Ownership Overview

54.44% Insiders

1.98% Mutual Funds

4.37% Other Institutional Investors

1.14% ETFs

38.07% Public Companies and

Individual Investors

The ownership structure of Kalaris Therapeutics (KLRS) stock is a mix of institutional, retail, and individual investors. Approximately 7.49% of the company’s stock is owned by Institutional Investors, 54.44% is owned by Insiders, and 38.07% is owned by Public Companies and Individual Investors.

The ownership structure of Kalaris Therapeutics (KLRS) stock is a mix of institutional, retail, and individual investors. Approximately 6.35% of the company’s stock is owned by Institutional Investors, 54.44% is owned by Insiders, and 1.14% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
May 22, 2026	Srinivas Akkaraju	xxxxxxxxxxxxx	$1179969
Mar 23, 2026	Brett R Hagen	xxxxxxxxxxxxx	$12869
Feb 17, 2026	Srinivas Akkaraju	xxxxxxxxxxxxx	$5000006

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	19,677,546	Insider	82.71%	92,878,017
	12,915,520	Insider	54.28%	60,961,254
	504,000	Insider	2.12%	2,378,880
	327,699	Institution	1.38%	1,546,739
	249,346	Institution	1.05%	1,176,913
Michael Rockefeller	100,000	Institution	0.42%	472,000
	74,608	Institution	0.31%	352,150
	69,551	Institution	0.29%	328,281
	30,838	Institution	0.13%	145,555
	22,500	Institution	0.09%	106,200

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	249,346	Institution	1.05%	1,176,913
	74,608	Institution	0.31%	352,150
	69,551	Institution	0.29%	328,281
	30,838	Institution	0.13%	145,555
	22,500	Institution	0.09%	106,200
	8,430	Institution	0.04%	39,790
	6,002	Institution	0.03%	28,329
	5,300	Institution	0.02%	25,016
	4,083	Institution	0.02%	19,272

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	255,337	Institution	1.07%	1,345,626
Vanguard Extended Market ETF	72,362	Institution	0.30%	381,348
iShares Micro-Cap ETF	8,699	Institution	0.04%	41,059
Dimensional US Core Equity 1 ETF	3,296	Institution	0.01%	15,557
Dimensional U.S. Core Equity 2 ETF	2,614	Institution	0.01%	11,894
BMO MSCI Innovation Index ETF	384	Institution	<0.01%	1,065
BMO MSCI Genomic Innovation Index ETF Trust Units	255	Institution	<0.01%	707

FAQ

Who Owns Kalaris Therapeutics (KLRS)?

According to the latest TipRanks data, approximately 4.37% of the company's stock is held by institutional investors, 54.44% is held by insiders, and 38.07% is held by retail investors.

What percentage of Kalaris Therapeutics (KLRS) stock is held by institutional investors?

According to the latest TipRanks data, approximately 4.37% of Kalaris Therapeutics (KLRS) stock is held by institutional investors.

What percentage of Kalaris Therapeutics (KLRS) stock is held by retail investors?

According to the latest TipRanks data, approximately 38.07% of Kalaris Therapeutics (KLRS) stock is held by retail investors.

Who owns the most shares of Kalaris Therapeutics (KLRS)?

David Hallal owns the most shares of Kalaris Therapeutics (KLRS).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.